Therapeutic efficacy of prosaposin-derived peptide on different models of allodynia

Pain

Volumn 121, Issue 1-2, 2006, Pages 14-21

  Jolivalt, Corinne G ^a   Ramos, Khara M ^b   Herbetsson, Katrin ^a   Esch, Fred S ^c   Calcutt, Nigel A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Myelos Neurosciences   (United States)

Author keywords

Allodynia; Painful neuropathy; Peripheral nerve injury; Prosaposin; Prosaptide

Indexed keywords

FORMALDEHYDE; PACLITAXEL; PROSAPOSIN; STREPTOZOCIN; TX 14 A;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; INFLAMMATION; NERVE INJURY; NEUROPATHIC PAIN; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PERIPHERAL NERVE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT;

ANALGESICS, NON-NARCOTIC; ANALYSIS OF VARIANCE; ANIMALS; DIABETES COMPLICATIONS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; NERVE GROWTH FACTORS; PACLITAXEL; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; SCIATICA; SKIN; TIME FACTORS;

EID: 32944465393     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2005.11.013     Document Type: Article

References (56)

1. S.C. Apfel, R.B. Lipton, J.C. Arezzo, and J.A. Kessler Nerve growth factor prevents toxic neuropathy in mice Ann Neurol 29 1991 87 90
2. N. Authier, J.P. Gillet, J. Fialip, A. Eschalier, and F. Coudore Description of a short-term Taxol-induced nociceptive neuropathy in rats Brain Res 287 2000 239 249
3. N.A. Calcutt, and S.R. Chaplan Spinal pharmacology of tactile allodynia in diabetic rats Br J Pharmacol 122 1997 1478 1482
4. N.A. Calcutt, W.M. Campana, N.L. Eskeland, L. Mohiuddin, K.C. Dines, A.P. Mizisin, and J.S. O'Brien Prosaposin gene expression and the efficacy of a prosaposin-derived peptide in preventing structural and functional disorders of peripheral nerve in diabetic rats J Neuropathol Exp Neurol 58 1999 628 636
5. N.A. Calcutt, J.D. Freshwater, and J.S. O'Brien Protection of sensory function and antihyperalgesic properties of a prosaposin-derived peptide in diabetic rats Anesthesiology 93 2000 1271 1278
6. N.A. Calcutt Potential mechanisms of neuropathic pain in diabetes Int Rev Neurobiol 50 2002 205 228
7. W.M. Campana, N. Eskeland, N.A. Calcutt, R. Misasi, R.R. Myers, and J.S. O'Brien Prosaptide prevents paclitaxel neurotoxicity Neurotoxicology 9 1998 237 244
8. W.M. Campana, L. Mohiuddin, R. Misasi, J.S. O'Brien, and N.A. Calcutt Prosaposin-derived peptides enhanced sprouting of sensory neurons in vitro and induced sprouting at motor endplates in vivo J Peripher Nerv Syst 5 2000 126 130
9. G. Cavaletti, G. Tredici, M. Braga, and S. Tazzari Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol Exp Neurol 133 1995 64 72
10. S.R. Chaplan, F.W. Bach, J.W. Pogrel, J.M. Chung, and T.L. Yaksh Quantitative assessment of tactile allodynia in the rat paw J Neurosci Methods 53 1994 55 63
11. K.D. Cliffer, J.A. Siuciak, S.R. Carson, H.E. Radley, J.S. Park, and D.R. Lewis Physiological characterization of Taxol-induced large-fiber sensory neuropathy in the rat Ann Neurol 43 1998 46 55
12. T.J. Coderre, A.L. Vaccarino, and R. Melzack Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection Brain Res 535 1990 155 158
13. A.H. Dickenson, and A.F. Sullivan Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurones Neurosci Lett 83 1-2 1987 207 211
14. P.M. Dougherty, J.P. Cata, J.V. Cordella, A. Burton, and H.-R. Weng Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients Pain 109 2004 132 142
15. D. Dubuisson, and S.G. Dennis The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats Pain 4 1977 161 174
16. M.J. Field, S. McCleary, J. Hughes, and L. Singh Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat Pain 80 1999 391 398
17. S.J. Flatters, and G.J. Bennett Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy Pain 109 2004 150 161
18. K.Y. Fu, A.R. Light, G.K. Matsushima, and W. Maixner Microglial reactions after subcutaneous formalin injection into the rat hindpaw Brain Res 825 1999 59 67
19. K.Y. Fu, A.R. Light, and W. Maixner Relationship between nociceptor activity, peripheral edema, spinal microglial activation and long-term hyperalgesia induced by formalin Neuroscience 101 2000 1127 1135
20. K.Y. Fu, A.R. Light, and W. Maixner Long-lasting inflammation and long-term hyperalgesia after subcutaneous formalin injection into the rat hind paw J Pain 2 2001 2 11
21. N. Fujita, K. Suzuki, M.T. Vanier, B. Popko, N. Maeda, and A. Klein Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids Hum Mol Genet 5 1996 711 725
22. C. Gillen, M. Gleichmann, P. Spreyer, and H.W. Muller Differentially expressed genes after peripheral nerve injury J Neurosci Res 42 1995 159 171
23. K. Harzer, B.C. Paton, A. Poulos, B. Kustermann-Kuhn, W. Roggendorf, and T. Grisar Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses Eur J Pediatr 149 1989 31 39
24. T. Hineno, A. Sano, K. Kondoh, S. Ueno, Y. Kakimoto, and K. Yoshida Secretion of sphingolipid hydrolase activator precursor, prosaposin Biochem Biophys Res Commun 176 1991 668 674
25. M. Hiraiwa, W.M. Campana, A.P. Mizisin, L. Mohiuddin, and J.S. O'Brien Prosaposin: a myelinotrophic protein that promotes expression of myelin constituents and is secreted after nerve injury Glia 26 1999 353 360
26. G.M. Khan, S.R. Chen, and H.L. Pan Role of primary afferent nerves in allodynia caused by diabetic neuropathy in rats Neuroscience 114 2002 291 299
27. Y. Kotani, S. Matsuda, M. Sakanaka, K. Kondoh, S. Ueno, and A. Sano Prosaposin facilitates sciatic nerve regeneration in vivo J Neurochem 66 1996 2019 2025
28. G. Levi, L. Minghetti, and F. Aloisi Regulation of prostanoid synthesis in microglial cells and effects of prostaglandin E2 on microglial functions Biochimie 80 1998 899 904
29. R.B. Lipton, S.C. Apfel, J.P. Dutcher, R. Rosenberg, J. Kaplan, and A. Berger Taxol produces a predominantly sensory neuropathy Neurology 39 1989 368 373
30. T. Liu, J.S. Walker, and D.J. Tracey Zinc alleviates thermal hyperalgesia due to partial nerve injury Neuroreport 10 1999 1619 1623
31. Z.D. Luo, N.A. Calcutt, E.S. Higuera, C.R. Valder, Y.H. Song, and C.I. Svensson Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin J Pharmacol Exp Ther 303 2002 1199 1205
32. W. Ma, W. Du, and J.C. Eisenach Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury Brain Res 937 2002 94 99
33. A.B. Malmberg, T.L. Yaksh, and N.A. Calcutt Anti-nociceptive effects of GM1 ganglioside derivative AGF44 on the formalin test in normal and streptozotocin-diabetic rats Neurosci Lett 161 1993 45 48
34. A.P. Mizisin, R.C. Steinhardt, J.S. O'Brien, and N.A. Calcutt TX14 (A), a prosaposin-derived peptide, reverses established nerve disorders in streptozotocin-diabetic rats and prevents them in galactose-fed rats J Neuropathol Exp Neurol 60 2001 953 960
35. J.S. O'Brien, and Y. Kishimoto Saposin proteins: structure, function, and role in human lysosomal storage disorders FASEB J 5 1991 301 308
36. J.S. O'Brien, G.S. Carson, H.C. Seo, M. Hiraiwa, S. Weiler, and J.M. Tomich Identification of the neurotrophic factor sequence of prosaposin FASEB J 9 1995 681 685
37. D.A. Otero, B. Conrad, and J.S. O'Brien Reversal of thermal hyperalgesia in a rat partial sciatic nerve ligation model by Prosaptide TX14(A) Neurosci Lett 270 1999 29 32
38. S. Patel, S. Naeem, A. Kesingland, W. Froestl, M. Capogna, L. Urban, and A. Fox The effects of GABA(B) agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat Pain 90 2001 217 226
39. E. Pinter, Z. Helyes, J. Nemeth, R. Porszasz, G. Petho, and M. Than Pharmacological characterisation of the somatostatin analogue TT-232: effects on neurogenic and non-neurogenic inflammation and neuropathic hyperalgesia Naunyn Schmiedebergs Arch Pharmacol 366 2002 142 150
40. R.C. Polomano, A.J. Mannes, U.S. Clark, and G.J. Bennett A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel Pain 94 2001 293 304
41. J.D. Pomonis, J.E. Harrison, L. Mark, D.R. Bristol, K.J. Valenzano, and K. Walker N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine- 1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. in vivo characterization in rat models of inflammatory and neuropathic pain J Pharmacol Exp Ther 306 2003 387 393
42. S. Puig, and L.S. Sorkin Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity Pain 64 1996 345 355
43. E.K. Rowinsky, E.A. Eisenhauer, V. Chaudhry, S.G. Arbuck, and R.C. Donehower Clinical toxicities encountered with paclitaxel (Taxol) Semin Oncol 20 1993 1 15
44. D. Schnabel, M. Schroder, W. Furst, A. Klein, R. Hurwitz, and T. Zenk Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is caused by a mutation in the initiation codon of their common gene J Biol Chem 267 1992 3312 3315
45. Z. Seltzer, R. Dubner, and Y. Shir A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury Pain 43 1990 205 218
46. Y. Shir, and Z. Seltzer A-fibers mediate mechanical hyperesthesia and allodynia and C-fibers mediate thermal hyperalgesia in a new model of causalgiform pain disorders in rats Neurosci Lett 115 1990 62 67
47. Y. Shir, A. Ratner, S.N. Raja, J.N. Campbell, and Z. Seltzer Neuropathic pain following partial nerve injury in rats is suppressed by dietary soy Neurosci Lett 240 1998 73 76
48. G. Villetti, M. Bergamaschi, F. Bassani, P.T. Bolzoni, M. Maiorino, and C. Pietra Antinociceptive activity of the N-methyl-d-aspartate receptor antagonist N-(2-indanyl)-glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain J Pharmacol Exp Ther 306 2003 804 814
49. E.M. Taylor, D.A. Otero, W.A. Banks, and J.S. O'Brien Retro-inverso prosaptide peptides retain bioactivity, are stable In vivo, and are blood-brain barrier permeable J Pharmacol Exp Ther 295 2000 190 194
50. L.R. Watkins, E.D. Milligan, and S.F. Maier Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain Adv Exp Med Biol 21 2003 1 21
51. D.M. White, and M.J. Cousins Effect of subcutaneous administration of calcium channel blockers on nerve injury-induced hyperalgesia Brain Res 801 1998 50 58
52. T.L. Yaksh, and T.A. Rudy Chronic catheterization of the spinal subarachnoid space Physiol Behav 17 1976 1031 1036
53. T.L. Yaksh, X.Y. Hua, I. Kalcheva, N. Nozaki-Taguchi, and M. Marsala The spinal biology in humans and animals of pain states generated by persistent small afferent input Proc Natl Acad Sci USA 96 1999 7680 7686
54. T. Yamamoto, O. Saito, K. Shono, T. Aoe, and T. Chiba Anti-mechanical allodynic effect of intrathecal and intracerebroventricular injection of orexin-A in the rat neuropathic pain model Neurosci Lett 347 2003 183 186
55. T. Yamamoto, S. Hirasawa, B. Wroblewska, E. Grajkowska, J. Zhou, and A. Kozikowski Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model Eur J Neurosci 20 2004 483 494
56. D.C. Yeomans, and H.K. Proudfit Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: electrophysiological evidence Pain 68 1996 141 150